Qube Research & Technologies Ltd - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 117 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$56,202
-69.4%
34,908
-37.7%
0.00%
-100.0%
Q4 2022$183,670
-16.5%
55,997
+136.6%
0.00%
-50.0%
Q1 2022$220,000
-27.9%
23,670
+20.7%
0.00%
-33.3%
Q2 2021$305,000
-74.0%
19,606
-76.0%
0.00%
-84.2%
Q1 2021$1,175,000
+32.3%
81,795
+80.9%
0.02%
+46.2%
Q4 2020$888,00045,2240.01%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$1,480,0007.58%
Redmile Group, LLC 6,280,813$9,295,6030.44%
Arctis Global LLC 397,046$587,6280.32%
Baupost Group 9,773,616$14,4650.28%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 230,000$413,4000.24%
MAVERICK CAPITAL LTD 6,290,713$9,310,2550.21%
683 Capital Management, LLC 1,200,000$1,776,0000.14%
STALEY CAPITAL ADVISERS INC 1,000,000$1,480,0000.08%
WASATCH ADVISORS LP 8,399,229$12,430,8590.08%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$777,0000.07%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders